Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengfu Xu

Showing results (71-80 of 142) with videos related to

Pageof 15
Sort By:
The Journal of Clinical Endocrinology and Metabolism|May 15, 2023
Remnant Cholesterol Independently Predicts the Development of Nonalcoholic Fatty Liver DiseaseHangkai Huang, Jiarong Xie, Yan Zeng, et al.
Annals of Nutrition & Metabolism|March 20, 2014
High serum ferritin levels increase the risk of hyperuricemia: a cross-sectional and longitudinal studyYa-nan Zhang, Chengfu Xu, Lei Xu, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 1, 2013
Animal models of chronic liver diseasesYan Liu, Christoph Meyer, Chengfu Xu, et al.
Plos One|September 7, 2012
Association between serum growth hormone levels and nonalcoholic fatty liver disease: a cross-sectional studyLei Xu, Chengfu Xu, Chaohui Yu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 18, 2019
Long noncoding RNA FLRL2 alleviated nonalcoholic fatty liver disease through Arntl-Sirt1 pathwayYi Chen, Xueyang Chen, Jianguo Gao, et al.
Journal of Gastroenterology and Hepatology|January 31, 2018
Risk for the development of non-alcoholic fatty liver disease: A prospective studyJinghua Wang, Liang Ma, Shenghui Chen, et al.
The Journal of Biological Chemistry|May 21, 2025
High uric acid exacerbates nonalcoholic steatohepatitis through NLRP3 inflammasome and gasdermin D-mediated pyroptosisZixin Xu, Chenxi Tang, Xin Song, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 20, 2013
A role of microRNA-370 in hepatic ischaemia-reperfusion injury by targeting transforming growth factor-β receptor IILan Li, Guogang Li, Chaohui Yu, et al.
Hepatology International|June 15, 2023
A simpler definition of MAFLD precisely predicts incident metabolic diseases: a 7-year cohort studyJiarong Xie, Lei Xu, Hangkai Huang, et al.
Biochemistry|May 7, 2011
Three-dimensional structure and catalytic mechanism of cytosine deaminaseRichard S Hall, Alexander A Fedorov, Chengfu Xu, et al.
Pageof 15

Showing results (71-80 of 142) with videos related to

Sort By:
Pageof 15
The Journal of Clinical Endocrinology and Metabolism|May 15, 2023
Remnant Cholesterol Independently Predicts the Development of Nonalcoholic Fatty Liver DiseaseHangkai Huang, Jiarong Xie, Yan Zeng, et al.
Annals of Nutrition & Metabolism|March 20, 2014
High serum ferritin levels increase the risk of hyperuricemia: a cross-sectional and longitudinal studyYa-nan Zhang, Chengfu Xu, Lei Xu, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 1, 2013
Animal models of chronic liver diseasesYan Liu, Christoph Meyer, Chengfu Xu, et al.
Plos One|September 7, 2012
Association between serum growth hormone levels and nonalcoholic fatty liver disease: a cross-sectional studyLei Xu, Chengfu Xu, Chaohui Yu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 18, 2019
Long noncoding RNA FLRL2 alleviated nonalcoholic fatty liver disease through Arntl-Sirt1 pathwayYi Chen, Xueyang Chen, Jianguo Gao, et al.
Journal of Gastroenterology and Hepatology|January 31, 2018
Risk for the development of non-alcoholic fatty liver disease: A prospective studyJinghua Wang, Liang Ma, Shenghui Chen, et al.
The Journal of Biological Chemistry|May 21, 2025
High uric acid exacerbates nonalcoholic steatohepatitis through NLRP3 inflammasome and gasdermin D-mediated pyroptosisZixin Xu, Chenxi Tang, Xin Song, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 20, 2013
A role of microRNA-370 in hepatic ischaemia-reperfusion injury by targeting transforming growth factor-β receptor IILan Li, Guogang Li, Chaohui Yu, et al.
Hepatology International|June 15, 2023
A simpler definition of MAFLD precisely predicts incident metabolic diseases: a 7-year cohort studyJiarong Xie, Lei Xu, Hangkai Huang, et al.
Biochemistry|May 7, 2011
Three-dimensional structure and catalytic mechanism of cytosine deaminaseRichard S Hall, Alexander A Fedorov, Chengfu Xu, et al.
Pageof 15